Table 3 The results of cardiac catheterization
From: Short-term study of atrial shunt and improvement of functional mitral regurgitation
Indicator | HFrEF | P | HFpEF+HFmrEF | P | ||||
|---|---|---|---|---|---|---|---|---|
Baseline (n = 10) | After implantation (n = 10) | 6 months follow-up (n = 7) | Baseline (n = 10) | After implantation (n = 10) | 6 months follow-up (n = 8) | |||
LAPm | 18.6 ± 4.7 | 11.6 ± 3.4 | 8.1 ± 5.4 |  < 0.001 | 17.0 ± 2.4 | 8.8 ± 3.2 | 9.3 ± 5.8 |  < 0.001 |
LAPs | 29.7 ± 12.4 | 18.8 ± 7.4 | 13.6 ± 5.4 | 0.004 | 24.7 ± 8.0 | 15.1 ± 6.1 | 18.3 ± 10.3 | 0.042 |
mRAP | 6.3 ± 1.6 | 5.5 ± 2.3 | 2.9 ± 2.3 | 0.008 | 4.8 ± 1.5 | 4.4 ± 1.8 | 4.5 ± 4.0 | 0.937 |
LA-RA gradiant | 12.3 ± 3.9 | 6.1 ± 3.5 | 5.3 ± 3.8 | 0.001 | 12.2 ± 1.8 | 4.4 ± 2.1 | 4.8 ± 2.1 |  < 0.001 |
PASP- | 44.3 ± 20.5 | 38.8 ± 16.4 | 16.6 ± 5.6 | 0.174 | 42.9 ± 10.6 | 36.9 ± 10.6 | 32.1 ± 12.2 | 0.139 |
Qp/Qs | 1.0 | 1.35 ± 0.14 | 1.35 ± 0.14 | 0.949 | 1.0 | 1.33 ± 0.13 | 1.35 ± 0.16 | 0.804 |
CI | 2.0 ± 0.7 | 2.3 ± 0.8 | 2.2 ± 0.4 | 0.591 | 2.0 ± 0.5 | 2.1 ± 0.5 | 2.4 ± 0.7 | 0.467 |